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IT was with particular pleasure that I accepted the honour of giving the W. E. Dixon Memorial Lecture, for as a young man I saw Dixon frequently in Cambridge. At that time the Pharmacological and Pathological Laboratories, of which only the fa9ade now remains to remind one of the architectural oddities that were hidden behind it, adjoined one another and there was a common tea-room. At our meetings over tea Dixon's lively conversation animated not only pharmacologists but even the more lethargic pathologists, while the younger members at the tea-table were much influenced in their general attitude to experimental science by contact with such an active investigator and interesting personality. With those happy memories of Dixon it may perhaps be appropriate if I commemorate him by discussing some of the difficulties that meet those who are trying to find a successful method of chemotherapy for tuberculosis, for in chemotherapy many disciplines meetthose of the chemist, of the bacteriologist and mycologist, of the pharmacologist, sometimes of the pathologist and the clinician.
Practically all our initial knowledge of the chemotherapy of bacterial diseases, like so many other things in medicine, has been obtained empirically, and it would be a bold man indeed who would discourage or belittle this method of approach. Nevertheless perhaps the time is coming when we can supplement purely empirical methods with those based on knowledge of the behaviour of chemotherapeutic agents not only in the test tube but in the body. I do not propose now to deal with the mode of action of antibacterial agents in vitro. The problem, essentially biochemical, of their action upon the bacterial cell has proved to be of great complexity, and it is probably correct to say that in spite of much work we are still ignorant of the fundamental biochemical lesion produced in bacteria by any of the naturally produced. antibacterial substances.
Mode of Action of Antibacterial Substances In Vivo
Relatively little attention has been paid to the mode of action of antibiotics in the animal body, so I propose firstly to discuss some of the phenomena associated with acute infections and their modification by antibacterial substances, and then to consider the more complicated conditions met with in tuberculosis. In spite of the degree of success that streptomycin and some other drugs have had, I suppose every clinician would agree that better antituberculous drugs are needed.
FEB.-EXPER. MED. 1 In searching for new antibiotics micro-organisms are examined for their production of substances that inhibit the growth of chosen bacteria or fungi. If an active substance is detected it is extracted, usually in a crude form, and produced in sufficient quantity to enable certain pharmacological tests to be made-especially regarding its toxicity. If it possesses no great toxicity its ability to inhibit the development of artificial infections in animals is examined. If these tests are encouraging the substance, after further purification and pharmacological investigation, is tried against infections in man. A similar series of investigations is carried out with synthetic substances suspected of being useful.
Although much attention is rightly given to investigations of the foregoing nature, little is usuallv given to consideration of the conditions that exist in the body during successful chemotherapeutic action.
The concentration of an antibacterial substance attained and maintained in the blood after parenteral or oral administration has, I think, rightly been taken as an indication of the concentration reached in normal body fluids. There is, however, an assumption here, and that is that the antibiotics of small molecular size such as penicillin and streptomycin pass freely to and fro through the walls of normal blood capillaries. This is probably so, but is by no means certain, as we have no knowledge of the effect of such factors as protein binding on any of the drugs in this connexion. It is certain that inflamed vessels in lesions caused by pyogenic organisms become more permeable and easily let through even large protein molecules into the exudate of the lesion. Chemotherapeutic agents escape from the blood into these exudates and, what is most interesting, some can thereafter be detected in the exudates for a considerably longer time than in the circulating blood.
The causative organisms of the pyogenic infections are for the most part free in the tissue fluids or inflammatory fluids-indeed many virulent organisms are only with difficulty taken up by granulocytes in the non-immune animal. One can conceive, however, and it was indeed the first explanation given of the action of penicillin in vivo, that if the growth of an invading organism is stopped by a chemical agent the defences of the body, principally the phagocytes, then ingest and demolish the organisms and so protect the animal or cure the patient, as the case may be.
That such a process is possible was shown by Avery and Dubos (1931) before the introduction of the present effective antibacterial agents. They found that intraperitoneal injection of an enzyme that split the carbohydrate of the capsule of type 3 pneumococcus removed the capsules from the pneumococci, which were then ingested and destroyed by phagocytes, so that the body was protected from infection, whereas the encapsulated organisms were practically unaffected by the phagocytes. Action of Penicillin and Other Antibiotics In Vivo Views of the mode of action of penicillin in vivo changed when it was clearly demonstrated in vitro that penicillin killed most dividing organisms, though a few "persisters" sometimes remained. Recently the mode of action in vivo of some antibiotics has been investigated at Oxford by Gowans and by Bowden. The parenteral administration of penicillin, Terramycin and Aureomycin sterilized lesions caused by the intradermal injection of pneumococci into rabbits, treatment starting six hours after infection. Untreated animals died twenty-four to forty-eight hours after infection. This sterilization occurred even in rabbits freed from most of their circulating granuloctyes by the administration of benzol, and in which the migration of such cells into infected tissue was negligible. Most of the pneumococci quickly became Gram-negative and were dispersed into fine granular debris. Thus the effects on the pneumococci were independent of phagocytosis. It is interesting that under the same conditions of experiment large intravenous doses of Sulphamezathine failed to protect either normal or leucopenic animals from the pneumococcal infection. In mice infected intraperitoneally with pneumococci or streptococci penicillin, Terramycin and Aureomycin caused a rapid diminution of the bacterial content of the peritoneal cavity when treatment was begun twelve hours after infection. This diminution appeared to be unassociated with any increase of phagocytosis. Again Sulphamezathine was ineffective under similar conditions. Thus there is some evidence that the antibiotics at present used in medicine owe their powers in vivo to their bactericidal properties and are not dependent on concurrent phagocytic activity, though this may at times be of some assistance.
Antibacterial Action in the Presence of Pus and Necrotic Tissue It appears relatively easy to understand what happens during the chemotherapy of an acute infection, lasting a few hours or days, in which there is little or no tissue destruction. When there is tissue destruction with the ultimate formation of pus the picture is different. 1 was once optimistic enough to believe that penicillin could be made fully effective even in the presence of considerable slough and pus. Extended experience has shown that this is not the case, and it has also demonstrated that the more chronic the infection the greater is the difficulty of removing the infecting bacteria. This is well illustrated by osteomyelitis caused by the staphylococcus. If the disease is diagnosed early, before tissue destruction has occurred, the inflammation can be caused to regress by the administration of penicillin alone. If an abscess has formed the pus must be evacuated in order to obtain a satisfactory chemotherapeutic effect. If bone has become chronically infected and there is dead bone present, no amount of penicillin, however administered, will sterilize the sequestra, and they must be removed surgically. The reasons for the failure of penicillin to sterilize slough or dead tissue are not clear, but the fact is worth keeping in mind as we go on to consider the possibilities of chemotherapy of tuberculosis, for penicillin in its own field is a very powerful bactericidal agent compared with the agents used against mycobacteria, and the lesions of tuberculosis nearly always contain necrotic tissue; Tissue Reactions to the Presence of Myco. tuberculosis 1 have mentioned at some length the possible behaviour of chemotherapeutic agents in the tissues in infections caused by bacteria that multiply primarily in extracellular fluid, to act as an introduction to the consideration of chemotherapy in the more complicated tissue reactions associated with the presence of tubercle bacilli. Perhaps I may be permitted briefly to recall the reaction that occurs in laboratory animals and in man to the presence of tubercle bacilli.
There is little if any direct evidence about the initial stages of the reaction to the presence of tubercle bacilli in man, but there is no reason. to suppose that the reaction in man differs substantially from that produced for experimental purposes in guinea-pigs and rabbits. Jensen, Bindslev and Holm (1935) have shown that in the lungs of the previously uninfected guinea-pig inhaled bacilli can first be detected in mononuclear cells in the walls of the alveoli, in which they divide until a cell may contain as many as 30 to 40 bacilli. After a few days there is a sudden development of the cellular reaction and many cells of macrophage type appear. This reaction is greatly accelerated in the previously infected or "immunized" animal. When bacteria injected intravenously are arrested in the lung there is a somewhat fleeting polymorph reaction that is soon replaced by a collection of large mononuclear cells many of which contain tubercle bacilli (Vorwald, 1932) . With the growth of the reaction it is supposed that more and more mononuclear cells appear and assume the somewhat specific form of epithelioid cells. At this stage it is probable that most of the tubercle bacilli are intracellular. With the growth of the tubercle, and the concurrent sensitization of the animal to tuberculo-protein, necrosis or caseation of the centre of the lesion occurs.
Observations In Vivo of Vascular Reactions Around a Tubercle
It is usually stated that a tubercle is avascular and published pictures of post-mortem injections of the blood vessels would certainly lead to such a conclusion. It is now possible to watch the development of a tubercle in vivo and so to follow early vascular reactions. Ebert, Ahern and Bloch (1948) and Ebert and Barclay (1950) , who were the first to do this, have described the tissue reactions occurring when tubercle bacilli are introduced through a removable plug in the back of a transparent chamber in a rabbit's ear. We have been able to confirm the observation of Ebert and his colleagues that changes which are obvious under low powers of the microscope begin somewhere between the tenth and fifteenth days after inoculation, and thereafter advance with some speed. The first change to attract the eye under low magnification is the emergence of opacities in which it is difficult to make out cell details-indeed it is possible that many of the cells are dead. These areas extend until in a -few days the tissue over the whole of the area under microscopic examination is necrotic. During this extension the blood-flow in the vessels at the periphery of the lesion, which are probably maximally dilated, first becomes slowed and usually oscillatory, and then passes on to stasis. The vessels containing blood in stasis become incorporated in the necrotic area and disintegrate. Leucocytes usually adhere in large numbers to the walls of the vessels near the tubercles.
The only substantial differences in the events seen in our chambers from those described by Ebert and his colleagues were that there was no increase of free tissue fluid during the growth of the tubercle, nor was dilatation of the blood vessels particularly noticeable. These slight differences were probably due to the layer of tissue being thinner in our chambers, and to its being more rigidly confined. Some chambers used by Sanders, Wells and Wylie (1949, unpublished) warped during their sojourn in the rabbit's ear so that the tissue became thicker than was intended. Tubercles growing in such chambers were surrounded by pulsating, widely dilated vessels, and much free fluid was present, as described by Ebert and his colleagues.
Penetration of Drugs into Tubercles
We are now in a position to appreciate how it is possible that the treatment of tuberculous infection '.by chemical means might have to differ from that of pyogenic infections.
There is little doubt that profound vascular changes occur around acutely developing tubercles, though these are probably not the primary cause of the necrosis which in this disease is commonly called caseation. It is clear, however, that drugs in the blood stream will have to penetrate considerable distances through necrotic and densely cellular tissue if they are to reach the bacilli that are often ,present in large-numbers in caseous material, and that they must also be able to enter macrophages and .epithelioid cells containing bacilli.
It is fairly certain that even the lesions that are detected at a so-called very early stage in man have usually evolved to the stage at which there is not only a substantial cellular reaction but also some necrosis. Many patients have extensive necrosis before it is recognized that they are ill, and great havoc can be caused in such an organ as the lung by chronic infection, marked by much fibrosis and cavitation, the disease gradually extending for many years.
The recognition as far as chemotherapy is concerned of the particular conditions existing in a tubercle is not new, and the problem was expressed very clearly by Wells and Long in 1932 before any antibacterial substances had been successfully introduced into therapeutics. They said:
"If we wish to destroy the tubercle bacilli in the body by specific chemotherapeutic measures we must consider not only what chemicals can kill the bacilli in the test tube but also which ones can penetrate the tubercle and pass through the wall of the phagocyte in which they are so often entrenched"; and "If the drug is to be a true chemotherapeutic agent in Ehrlich's sense, that is, a substance that kills bacteria and spares-the host because it has a high selective affinity for the bacterial protoplasm and a low affinity for the protoplasm of the host, it must be able to penetrate the tubercle, the phagocytic cell if the bacilli are enclosed within cells, and the tubercle bacillus . . " Though the problem was thus clearly stated at least twenty years ago no particular attention seems to have been paid lately to the effect of the complicated structure of tuberculous lesions and the protected position of the bacilli, either inside phagocytes or buried in caseous material, on the possible therapeutic action of drugs in vivo.
The'procedure adopted for finding agents active against organisms producing acute inflammatory lesions has been adopted in searching for drugs active against the tubercle bacillus. Thus natural antibiotics or synthetic substances are tested for their capacity to inhibit the growth of the tubercle bacillus in vitro; if they are active their toxicity is tested in animals, and if this is not too great they are tested for their effects on the acute tuberculous lesions caused by the injection of bacilli into experimental animals such as guinea-pigs or mice.
All the substances that are at present being tested for antituberculous activity are water-soluble and have small molecules, and one can conceive that after entry into the blood stream they spread more or less evenly in the extravascular fluids and possibly may also diffuse into caseous material and have some effect on the bacilli growing there. But such drugs do not necessarily penetrate into mononuclear cells harbouring bacilli. By a series of somewhat halting steps we have been led to examine in some detail the possibilities of bringing the drugs more closely to the bacilli.
Effects of Micrococcin on Tubercles
In 1948 Su, a Chinese bacteriologist working in Oxford, isolated from Oxford sewage a micrococcus which produced an antibiotic active against a number of Gram-positive organisms, the growth of some of them, for example the staphylococcus and streptococcus, being inhibited at a dilution as great as 1 : 30,000,000, though there was a considerable inoculum size effect and resistant strains could easily be produced. The tubercle bacillus was sensitive to the action of the antibiotic in vitro but much less so than the organisms mentioned. Micrococcin, as the substance was called, is remarkably insoluble in water. Heatley estimated that its solubility is of the order of 1 ug. in l ml. of distilled water, though supersaturated solutions can occur. The tubercle bacillus is not inhibited by a concentration of I ug./ml. and it is indeed difficult to fix a figure in the usual way. From the point of view of the experiments to be described it was sufficient to show that solid micrococcin applied to the surface of a culture medium inhibits the growth of the tubercle bacillus where the solid substance is placed.
The possession of this almost insofuble substance gave rise to the idea that it might be possible to induce monocytes and macrophages to phagocytose micrococcin, and so to concentrate it within the actual cells in which bacilli were living and dividing in growing tubercles. If this could be done the macrophages and possibly the epithelioid cells to which they give rise might be "fortified" by the antituberculous agent and thus might have their capacity to demolish tubercle bacilli, which is not naturally great, increased.
Indian inkl was first used as a "model" for the behaviour of micrococcin, and was injected intravenously into rabbits with developing tubercles. If the ink was given within ten days of the intravenous injection of tubercle bacilli carbon particles were found in the epithelioid cells, and even in the caseous centre, of tubercles of liver, spleen and lung. When given later than ten days after infection, it only appeared in the tubercle in scattered macrophages. It seemed worth while, therefore, to see what effect micrococcin injected within ten days of infection would have on the development of experimental tubercles.
Firstly it was shown by a variety of means that the substance was innocuous when injected intravenously, subcutaneously and intrathecally in a finely particulate form into mice, guinea-pigs and rabbits, as long as care was taken not to introduce particles large enough to embolize large vessels in the lung or heart. The micrococcin was taken up by cells of the reticulo-endothelial system and some remained in the body for months, though it was gradually eliminated. It caused no apparent damage to cells that had taken it up, whether connective tissue, macrophages, Kupffer cells or phagocytic cells of the spleen. It was easy to show that macrophages phagocytosed micrococcin locally applied in transparent chambers in the rabbit's ear. The follow-up of the fate of tha micrococcin was facilitated by the fact that the substance fluoresces brilliantly in ultraviolet light.
Summarizing these preliminary experiments, it appeared that carbon particles could be introduced into tubercles from the blood stream if given soon enough after infection, and that micrococcin which was active against the tubercle bacillus in vitro, could be introduced into phagocytic cells without harming them. ft seemed worth while to try to treat experimental tuberculosis by the intravenous injection of the particulate antibiotic.
The Failure of Particulate Micrococcin. Its Behaviour after Intravenous Iinjectionl The first experiments were done on rabbits infected intravenously with bovine bacilli. With the dose of organisms used rabbits usually die in about thirty days. Later, guinea-pigs were used, a human strain of bacillus being injected intramuscularly.
The lives of the treated animals were not prolonged by frequent intravenous injections of finely particulate micrococcin, although the reticulo-endothelial cells of the spleen and liver were well filled with the drug. The development of the tuberculous process was slowed at first if the micrococcin was given soon after infection, for example on the fifth day, but eventually the lesions progressed as in untreated animals. There were a number of possible explanations for the failure of the micrococcin to prevent the extension of the experimental tubercles. One was that the antibiotic did not in fact reach the zells that contained the tubercle bacilli. It was thought that some light might be thrown on this matter if the behaviour of the injected suspension of micrococcin in the blood stream were watched by ultraviolet light in normal uninfected tissue in a transparent chamber in the rabbit's ear. About one minute after the beginning of an intravenous injection, during which 10 to 20 ml. containing about 200 mg. of micrococcin were given in five to six minutes, fluorescent particles were seen passing along the vessels. These particles were much larger than those that had been injected. Although the fine particles were not agglutinated by serum they became caught up with blood platelets soon after they entered the blood stream and formed masses of the size of blood cells or larger. Few of the aggregates were large enough actually to embolize the small vessels, but they became adherent to the vessel walls where they showed as brilliantly fluorescent particles. The masses were found particularly in vessels of which the walls were "sticky", shown by the adhesion of leucocytes, such as are present in the growing edge of the normal tissue of a chamber.
These masses were not easily displaced and some remained attached to the vessel walls for days. Little if any of the substance was taken up by extravascular macrophages, although these were plentiful in the surrounding tissue, and only when the vascular pattern changed, as it does fairlv often in growing tissue, did some become extravascular. Some direct observations were made of the effect of intravenously injected micrococcin on a very young tubercle in a transparent ear chamber. Micrococcin particles adhered to the walls of the vessels that were patent alongside the growing tubercle, and much of this was still present in the same position after the vessels had thrombosed and been incorporated in the tubercle. All the same, it had no apparent effect on the growth of the tubercle, nor did it seem to be distributed in the phagocytic cells, even at the periphery of the lesion.
From all this work it was clear that the injection of this particulate antibiotic into the blood stream did not offer much hope of introducing it into the cells of a tubercle, so another approach, again with micrococcin, was made.
Effect of Micrococcin Dissolved with Triton
It had been shown long ago that vital dyes such as trypan blue, which form colloidal aggregates, could enter a tubercle and even stain the caseous centre, so an attempt was made to form a colloidal solution of micrococcin. Heatley found that Triton WR-1339, a non-ionic detergent which appears to produce no damage to an animal even after large amounts have been injected intravenously, can "dissolve" micrococcin, producing a solution with the consistency of dilute egg white when 5 mg. per ml. are present. The product is probably of the nature of a colloidal solution. Considerable amounts of this mixture could be injected intravenously, and after repeated injections fluorescent material could be recognized in Kupffer cells and cells of the red pulp of the spleen, where it remained for many weeks. There was evidence that a little of the micrococcin went into extravascular macrophages, but it scarcely passed out even from the very permeable capillaries of the gut, as little was found in -thoracic duct lymph of a rabbit. The repeated intravenous injection of micrococcin-Triton solution into guinea-pigs with experimental tuberculosis produced no effect on the survival time of the animals or on the growth of the tubercles, and though many phagocytic cells containing micrococcin were visible at the periphery of tubercles in the spleen none was seen within them.
Penetration of Dyes into Tubercles
These experiments with micrococcin, though they failed in their primary purpose, have directed our attention to the state of the permeability of blood vessels around growing tubercles. In acute inflammation caused by pyogenic organisms blood vessels have their permeability greatly increased by the liberation of chemical substances by damaged tissues. We have seen that blood vessels can become involved in tuberculous necrosis, but what is their state in earlier lesions or before the necrosis reaches them? The fact that trypan blue and other vital dyes have been said to penetrate into rapidly growing tubercles suggests that the walls of capillaries are more permeable than normally. We have found that after even a single intravenous injection of Evans blue, which combines with plasma proteins, the dye leaves the blood stream and diffuses throughout a small tubercle. It seems probable, therefore, that in the neighbourhood of acute tubercles of animals the capillary endothelium is more permeable than normal, and this may well apply to man. What the state of the vessels is around the chronic lesions of man it is at present impossible to say.
The Effect of Tuberculin The permeability of vessels near tubercles can be somewhat specifically increased by making use of the focal reaction that follows the intravenous injection of tuberculin. It is fairly clear that permeability is increased during a focal tuberculin reaction since exudates, presumably rich in protein, are formed. The increased capillary permeability following a tuberculin reaction can be demonstrated by vital dyes. For example it can be shown in guinea-pigs that considerably more dye appears around lesions caused by the intramuscular injection of BCG after an intravenous injection of Old Tuberculin than around lesions not subjected to the influence of tuberculin.
The question of the effect of tuberculin on vascular permeability, and hence on the access of drugs to tubercles, may be of some immediate interest, as already, though on other grounds, attempts are being made to enhance the effects of antibiotics such as streptomycin by the simultaneous use of tuberculin.
From these experimental findings and speculations it may perhaps be legitimate to suggest that the best type of chemotherapeutic agent for use in tuberculosis may prove to be one of large molecular size or attached to a large molecule, which would emerge from the blood stream where vessels were more permeable than normal and once having emerged would, like proteins, leave the extravascular fluid with difficulty except by way of the lymphatics. This advantage might be coupled with that conferred by the ability of macrophages to segregate and concentrate large molecular aggregates such as vital dyes, so that a high concentration of antibiotic might be produced intracellularly. No doubt small easily diffusible molecules may be effective in tuberculosis, as is shown by the results obtained with streptomycin, but these substances can diffuse in and out of lesions so freely that doses have to be frequently repeated and it is difficult to keep up an effective concentration especially in the interior of a lesion.
The Effect of Cortisone
There is now a considerable amount of evidence that cortisone will diminish the action of trauma and of certain chemical substances in increasing capillary permeability. There is probably a similar effect on the vessels around tubercles, for Ebert (personal communication) has demonstrated some remarkable alterations in the vessels of infected tissue in rabbit's ear chambers under the influence of cortisone. It is tempting to suggest that to regulate the access of a chemotherapeutic agent to tuberculous lesions one might increase and diminish the permeability of the surrounding vessels at will by the alternating use of tuberculin and cortisone. Unfortunately cortisone seems to have other effects in tuberculosis, for in both animals and man it appears to increase or even to provoke the spread of the inflammatory process.
Penetration of Drugs into Cells
You will remember that besides the question of penetration of a drug into the tuberculous lesion there was that of its penetration into phagocytic cells before or after they had acquired a population of tubercle bacilli. This can be envisaged as taking place in three ways-by the phagocytosis of particles, or by the selective uptake of large molecules analogous with the vital dyes, or by a less specific passage of substances through the cell membrane. This question has been investigated by Mackaness, who has devised an ingenious technique whereby it is possible to observe in vitro for many days the effect on tubercle bacilli that are contained within rabbit macrophages of drugs dissolved or suspended in the surrounding fluid medium. He will himself soon be describing his technique and the results obtained with it, but he allows me to give the following facts.
Inside a normal macrophage the coccobacillary forms derived from a three-weeks-old culture of virulent bovine bacilli (Branch strain) can be seen to be increasing in length after about twenty-four hours' incubation. At the end of forty-eight hours small cords of bacilli can be found in the cytoplasm, and soon after this sign of bacillary multiplication is seen, the macrophage dies and liberates the 6 bacilli into the surrounding medium. It seems possible that an insight may be quickly gained into the probable efficacy of an antituberculous drug in the whole animal by observing the behaviour of the intracellular parasite when the drug is present in the surrounding medium.
A number of substances have been examined. When in particulate form the substance micrococcin, which first initiated this work, was taken up by the macrophages, but the growth of bacilli, which was at first retarded by its presence, was not suppressed and the macrophages were eventually killed. The colloidal micrococcin-Triton preparation was little more effective, for at a concentration of 100 jtg./ml. in the culture medium it only retarded death of the cells. In contrast to this a concentration of 10 ,ag. of streptomycin per ml. in the culture medium, but not 5 tg./ml., would inhibit the growth of the bacilli and preserve the life of the cells. We do not know much about the behaviour of streptomycin towards such cells, but it seems likely that it penetrates through the cell wall in a non-specific way.
It is thus possible to show that streptomycin can stop the intracellular growth of virulent mycobacteria, but even when growth is inhibited for many days the cells themselves are unable to kill the bacilli. They can, however, kill bacteria of the avirulent H37Ra strain in the course of a few days even without the aid of streptomycin. The human strain of tubercle bacillus H37Rv appears to be less sensitive to streptomycin than the bovine strain when inside macrophages.
In similar experiments to those mentioned above it has been shown that para-aminosalicylic acid cannot completely inhibit the virulent bovine bacillus even at concentrations of 100 yg./ml. Terramycin, on the other hand, is as active against intracellular as it is against extracellular bacilli. Complete inhibition is produced with this drug by a concentration in the medium of 12 5 ,ug./ml. These experiments show that the concentration of streptomycin that has to be present in the fluid round the macrophages in vitro in order to inhibit the growth of intracellular organisms is considerably -of the order of at least ten times-greater than that required to inhibit the growth of tubercle bacilli in Dubos and Davis's fluid medium. In fact, growth is only fully inhibited by a concentration around the macrophages usually considered to be above that which can be maintained for any length of time in the body fluids. But of course we do not know what concentration of the drug is present at the point of action inside the cell.
It would seem that this method of examining antituberculous drugs may be of considerable value in estimating their possible performance in vivo as it separates out one factor for study, namely the behaviour of the drug towards intracellular bacilli. We do not, of course, know whether the cells, which remain actively motile in vitro for many days, retain all the properties they possess in the intact body, but there are no reasons to suppose that they do not.
Desirable Properties in a Cheniotherapeutic Agent
With these experiments and speculations in mind perhaps one may attempt to define the qualities that might be worth looking for or incorporating in substances to be examined for their antituberculous action in vivo. One can, as is usually done at present, look for easily diffusible substances of small molecular size. If sufficiently non-toxic and frequently administered such a drug might be quite satisfactory. But another possibility exists, and that is, to use substances of relatively large molecular size, or substances firmly bound to large molecules, which do not diffuse readily from normal blood vessels but which could be made to enter tubercles somewhat selectively by their capacity to pass through the walls of capillaries whose permeability is increased. To give any hope of usefulness such a substance should be able to inhibit the growth of the tubercle bacillus in vitro at great dilution, should for preference be bactericidal rather than bacteriostatic in low concentrations, should be able to penetrate macrophages and possibly epithelioid cells, and should be concentrated by these cells in the manner of a vital dye. It would be highly desirable that the tubercle bacillus should only acquire resistance to the drug slowly, if at all, for under the best conditions likely to be attained treatment of established tuberculosis must still be prolonged, and therefore the bacillus would be subject to the action of the drug for a considerable time. The drug would, no doubt, be segregated by cells of the reticulo-endothelium such ay are present in the spleen and liver. As it would remain in these and other parts of the body for a considerable time it would need to have low toxicity for cells in general, and in particular for the kidneys, liver and other organs where it might be concentrated. Also it must not be carcinogenic. At present I know of no compound having these properties. I put forward these propositions in case among the many thousands of synthetic compounds that have been and are being produced, and among the many antibiotics that are being extracted, one or more may be found to have at least some of the required properties, so that the proposals can be tested.
Treatment of Human Tuber-culosis
Supposing that one could successfully achieve in experimental animals cure of tuberculous infection on the lines that I have suggested, would all be set fair for the treatment of human tuberculosis? I very much doubt it.
It may be useful to emphasize again that the lesions in animals on which drugs are tested are of a relatively acute nature, but that most lesions in man are chronic. They are characterized by necrosis, sloughing and liquefaction, and fibrosis. In the lungs cavities which usually communicate with bronchi are formed. Bacilli may grow in enormous numbers in the slough lining the cavities. To accomplish the eradication of bacilli from such lesions and to secure complete healing is indeed a formidable undertaking. It is unfortunate that the ability of the body to dispose of necrosed tuberculous tissue is so poor, and that liquefaction of a necrotic focus often seems to produce conditions favourable for the growth of the tubercle bacillus.
As I have already mentioned, there are good reasons for believing that the ptesence of slough or pus that cannot escape to the exterior hinders or prevents the sterilization of staphylococcal lesions by penicillin even though the organisms are to a considerable extent extracellular. It is probable that much the same applies to the treatment of tuberculosis in which slough, represented'by tuberculous caseation, is present.
Some experimental evidence is to hand to support this view. Steenken and Wolinsky (1950) pointed out that the abscess that forms in a guinea-pig at the site of injection of tubercle bacilli, and at times the abscesses in the regional lymph glands, are not sterilized even after the uninterrupted administration of streptomycin for 528 days. When these abscesses discharge or are drained healing is likely to occur. These authors also studied the chronic lesions that occur in immunized guinea-pigs or follow the suppression of lesions for some time by streptomycin. In one experiment the disease was allowed to progress for 96 days and then treatment with streptomycin was given for 300 days. Of 7 animals killed at the end of treatment 3 had gross lesions consisting of cyst-like structures, in the liver, spleen and lungs, teeming with bacilli that had acquired no significant resistance to streptomycin. The authors point out that this contrasts with' the uniformly successful suppression by streptomycin of the acute form of the disease in guinea-pigs. One might well despair of being able to do much with chronic tuberculous lesions in man if it were not for the fact that we know that healing of extensive lesions can occur without chemotherapy, and that the tendency to healing is nearly always strong.
There is one conclusion that can be drawn with great force from these considerations, and that is that early diagnosis and treatment of tuberculosis' are absolutely essential for the really successful use of a chemotherapeutic agent. The smallest lesions of active tuberculosis that are now clinically recognizable have almost certainly undergone necrosis, so that even in these treatment will have to be continued for a long time to allow of full healing.
One could perhaps go so far as to conceive of a drug so little toxic to the body that it could be used periodically as a prophylactic in very much the same way as antimalarial drugs are used at the present time. At present we are far from this goal.
It is clear that much remains to be done in understanding the problems of chemotherapy even of experimental tuberculosis in animals. Progress is being made, however, and if any of the experiments I have mentioned or suggestions I have made lead to further experiments I shall be very grateful.
In this lecture I have used freely the results obtained by many colleagues in my department. In particular Drs. Markham, Mackaness, Sanders, Heatley, Wells and Dodson have done much of the experimental work I have mentioned. I am greatly indebted to them. Perhaps Dixon would be pleased to see how in these days pharmacological investigations have a more and more potent influence on therapeutics, how in certain directions the findings of the pharmacologist may with profit be integrated with those of the pathologist, and how the combined observations of the two may directly concern those whose primary interest is the care of patients.
[The lecture was illustrated by slides.]
